Eakin Healthcare Surgical has unveiled a new brand identity as part of its gradual transition to the Eakin Healthcare branding.
Over the last couple of months, the Cardiff-based company has introduced a gradual transition, with the new identity reflecting the group’s vision.
Surgical’s Commercial Director, Jon Blastland, said:
“We are excited to share our new branding as Eakin Healthcare’s Surgical therapy area.
“We continue to distribute our pioneering single-use surgical instruments products to over 30 countries worldwide, and with a focus on expanding our global reach, we look forward to meeting and building relationships with new distributors and partners through the brand transition to Eakin Healthcare.”
Years of consultation with hospitals and clinicians has led to Eakin Healthcare’s Surgical team developing its comprehensive ranges of single use suction tubes.
Each instrument has been designed to match the high quality, ease-of-use and functionality of the reusable equivalent, but are guaranteed clean and sterile and deliver cost and efficiency savings.
The company aims to enable safer operations and improved patient outcomes through the provision of high-quality surgical solutions.
The company works closely with healthcare professionals to identify where products can be improved and bring to market innovative solutions that offer surgical teams the reliable, practical and flexible tools that they rely on.
Eakin Healthcare’s Surgical team manufactures high-quality single use surgical instruments sold worldwide.
Their solutions have been designed in response to increasing concerns over the cleaning of reusable fine lumen instruments – which are associated with high risks of patient-to-patient cross-infection.
With a manufacturing facility based in Cardiff, South Wales, the company has a clean room and ethylene oxide sterilisation facilities and is supported by an experienced technical and R&D team.
“These relationships extend across Europe, Australia, New Zealand, South Africa, the Middle East, and Asia.
“As we move forward with developing our international partners, we have identified several key markets including Latin America, Brazil, and the Far East.
“We also work closely with the Welsh Government in their export market promoting our products worldwide at prestigious exhibitions such as Medica & Arab Health.”
Urgent work needed to tackle ‘substantial’ digital health inequality
eSight: “The technology has the potential to change someone’s life”
Microsoft invests £2.5 billion in UK AI
TMS shows promise in tackling depression ‘epidemic’
AI depression app set for NHS clinical trial
UK Biobank releases world’s largest single set of sequencing data
Listen: Longevity, Eastern wisdom and Western science
Fundamental principles of healthcare digital twins
Tackling the diagnostic testing sustainability problem
Gym-going men ‘unaware’ of protein risk to fertility
- News3 weeks ago
Why a leading healthcare CEO sees recombinant DNA as a metaphor for developing breakthrough technologies
- AI5 days ago
AI model predicts breast cancer risk without racial bias
- Medtech4 weeks ago
Surtex Instruments to unveil game-changing Infinex microsurgery instruments at MEDICA
- AI2 weeks ago
Humans make better cancer treatment decisions than AI, study finds